• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comments on the original article by Soubrier et al. "Effects of anti-tumor necrosis factor therapy on lipid profile in patients with rheumatoid arthritis".

作者信息

Seriolo Bruno, Paoliono Sabrina, Ferrone Carmela, Cutolo Maurizio

出版信息

Joint Bone Spine. 2009 Jan;76(1):117-8; author reply 118. doi: 10.1016/j.jbspin.2008.09.004. Epub 2008 Dec 11.

DOI:10.1016/j.jbspin.2008.09.004
PMID:19084458
Abstract
摘要

相似文献

1
Comments on the original article by Soubrier et al. "Effects of anti-tumor necrosis factor therapy on lipid profile in patients with rheumatoid arthritis".对苏布里耶等人原创文章《抗肿瘤坏死因子治疗对类风湿关节炎患者血脂谱的影响》的评论
Joint Bone Spine. 2009 Jan;76(1):117-8; author reply 118. doi: 10.1016/j.jbspin.2008.09.004. Epub 2008 Dec 11.
2
The effects of TNF-alpha blocking therapy on lipid levels in rheumatoid arthritis: a meta-analysis.肿瘤坏死因子-α阻断疗法对类风湿关节炎患者血脂水平的影响：一项荟萃分析。
Semin Arthritis Rheum. 2012 Feb;41(4):e4-5; author reply e6. doi: 10.1016/j.semarthrit.2011.10.002. Epub 2011 Dec 9.
3
Effects of etanercept or infliximab treatment on lipid profile and insulin resistance in patients with refractory rheumatoid arthritis.依那西普或英夫利昔单抗治疗对难治性类风湿关节炎患者血脂谱和胰岛素抵抗的影响。
Clin Rheumatol. 2007 Oct;26(10):1799-800. doi: 10.1007/s10067-007-0702-2. Epub 2007 Jul 24.
4
Lipid profile of rheumatoid arthritis patients treated with anti-tumor necrosis factor-alpha drugs changes according to disease activity and predicts clinical response.接受抗肿瘤坏死因子-α药物治疗的类风湿关节炎患者的血脂谱根据疾病活动情况而变化，并可预测临床反应。
Drug Dev Res. 2014 Nov;75 Suppl 1:S77-80. doi: 10.1002/ddr.21203.
5
Demonstration of response in rheumatoid arthritis patients who are nonresponders according to the American College of Rheumatology 20% criteria: the paradox of beneficial treatment effects in nonresponders in the ATTRACT trial. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy.
Arthritis Rheum. 2001 Nov;44(11):2703-4. doi: 10.1002/1529-0131(200111)44:11<2703::aid-art451>3.0.co;2-e.
6
Comments on Falgarone et al. editorial entitled "TNFalpha antagonists in rheumatoid arthritis patients seen in everyday practice".
Joint Bone Spine. 2008 Oct;75(5):626; author reply 626. doi: 10.1016/j.jbspin.2008.01.028. Epub 2008 Sep 20.
7
[TNF antagonists in therapy of rheumatoid arthritis].[肿瘤坏死因子拮抗剂在类风湿关节炎治疗中的应用]
Med Monatsschr Pharm. 1999 Nov;22(11):334-9.
8
Increase in plasma levels of adiponectin after administration of anti-tumor necrosis factor agents in patients with rheumatoid arthritis.类风湿关节炎患者使用抗肿瘤坏死因子药物后血浆脂联素水平升高。
J Rheumatol. 2008 May;35(5):936-8.
9
Comments about the editorial by Bénédicte Mugnier and Jean Roudier entitled "Factors predicting responsiveness to anti-TNFalpha therapy in patients with rheumatoid arthritis: using biotherapies rationally".关于贝内迪克特·穆尼耶（Bénédicte Mugnier）和让·鲁迪耶（Jean Roudier）题为《类风湿关节炎患者抗TNFα治疗反应的预测因素：合理使用生物疗法》的社论的评论
Joint Bone Spine. 2005 Jul;72(4):346-7; author reply 347-8. doi: 10.1016/j.jbspin.2005.01.004. Epub 2005 Mar 24.
10
The effect of smoking on response and drug survival in rheumatoid arthritis patients treated with their first anti-TNF drug: comments on the article by Söderlin et al.
Scand J Rheumatol. 2012 Oct;41(5):411-2. doi: 10.3109/03009742.2012.698394.

引用本文的文献

1
ApoM Suppresses TNF-α-Induced Expression of ICAM-1 and VCAM-1 Through Inhibiting the Activity of NF-κB.载脂蛋白M通过抑制核因子κB的活性来抑制肿瘤坏死因子-α诱导的细胞间黏附分子-1和血管细胞黏附分子-1的表达。
DNA Cell Biol. 2015 Aug;34(8):550-6. doi: 10.1089/dna.2015.2892. Epub 2015 Jun 9.
2
Modifications in lipid levels are independent of serum TNF-α in rheumatoid arthritis: results of an observational 24-week cohort study comparing patients receiving etanercept plus methotrexate or methotrexate as monotherapy.类风湿关节炎患者血脂水平的改变与血清肿瘤坏死因子-α无关：一项为期24周的观察性队列研究结果，该研究比较了接受依那西普联合甲氨蝶呤或甲氨蝶呤单药治疗的患者。
Biomed Res Int. 2014;2014:510305. doi: 10.1155/2014/510305. Epub 2014 Aug 27.
3
Dyslipidemia and changes in lipid profiles associated with rheumatoid arthritis and initiation of anti-tumor necrosis factor therapy.
类风湿关节炎与抗肿瘤坏死因子治疗相关的血脂异常及血脂谱变化。
Arthritis Care Res (Hoboken). 2012 Sep;64(9):1282-91. doi: 10.1002/acr.21693.
4
A systematic review of the effect of TNF-alpha antagonists on lipid profiles in patients with rheumatoid arthritis.一项关于 TNF-α拮抗剂对类风湿关节炎患者血脂谱影响的系统评价。
Clin Rheumatol. 2010 Sep;29(9):947-55. doi: 10.1007/s10067-010-1405-7. Epub 2010 Apr 10.